The strategic advantages of X-ray Fluorescence for pharmaceutical elemental analysis

The strategic advantages of X-ray Fluorescence for pharmaceutical elemental analysis

Brought to you by Malvern Panalytical

Overview

Unlock the future of pharmaceutical elemental analysis with X-ray fluorescence (XRF) spectroscopy. This white paper explores how XRF outperforms traditional methods like inductively coupled plasma (ICP) spectroscopy, offering faster, simpler, and safer sample preparation with non-destructive analysis.

Discover how XRF accelerates drug development, reduces bottlenecks, cuts costs, and supports sustainability efforts while improving safety. Download the white paper now and optimize your approach to elemental analysis.

Key Objectives:

Understand the operational and cost benefits of X-ray fluorescence (XRF) over ICP spectroscopy for pharmaceutical analysis.
Learn how XRF simplifies sample preparation and improves workflow efficiency.
Explore XRF’s role in enhancing safety and sustainability in drug development.
Recognize the strategic value of XRF for regulatory compliance and scale-up processes.
Discover practical applications of XRF in real-world pharmaceutical settings.

Brought to you by:

This content was created by Malvern Panalytical, without editorial input from the C&EN Media Group. For more information on C&EN's custom products, visit our C&EN Media Kit.

Please complete the form to download the white paper.

Forwarded this link? Clear the form

Email Address*

Salutation*

First Name*

Last Name*

Company*

Job Title

Address 1*

City*

State*

Zip / Post Code*

Country/Territory/Area*

Business Phone*

I would like to be contacted by phone or email by a Malvern Panalytical representative

I would like to receive C&EN’s weekly newsletter with the latest in chemistry news

I would like to receive more information on products and services from the American Chemical Society

address2

*For full details of how Malvern will use your information please view our privacy policy.

*By submitting this form, you agree to receive more information on related products and services from the American Chemical Society (ACS Publications) and its sponsor via email. ACS takes your privacy seriously. For more information, please see the ACS Privacy Policy.